Promedius (CEO Bae Hyeon-jin) , an AI company specializing in aging and metabolic diseases, announced on September 18 that it had signed an AI linkage agreement with Siemens Healthineers China.
The agreement will integrate Promedius' chest X-ray-based osteoporosis screening AI software, Osteo Signal, with Siemens Healthineers' research platforms, including the AI-Rad Companion Research Frontier and Syngo.via Frontier Research Platform.
Osteo Signal will be utilized by hospital customers in clinical settings in China through the Siemens Healthineers Research Platform. Promedius plans to continuously improve product performance based on real-world research data and customer feedback, demonstrating clinical value and strengthening its global partnership with Siemens Healthineers.
“This contract is the first step in building an AI preventive healthcare ecosystem by combining Siemens Healthineers’ global infrastructure and Promedius’ AI technology,” said Bae Hyun-jin, CEO of Promedius. “We will further enhance the performance of Osteo Signal, expand its reach into the global market, and achieve our mission of ‘Healthy Aging through AI.’”
- See more related articles
You must be logged in to post a comment.